SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-227138
Filing Date
2020-08-21
Accepted
2020-08-21 17:31:01
Documents
3
Effectiveness Date
2020-08-21

Document Format Files

Seq Description Document Type Size
1 S-8 d250265ds8.htm S-8 74047
2 EX-5.1 d250265dex51.htm EX-5.1 4539
3 EX-23.1 d250265dex231.htm EX-23.1 1667
  Complete submission text file 0001193125-20-227138.txt   81291
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-248249 | Film No.: 201124257
SIC: 2836 Biological Products, (No Diagnostic Substances)